Valeant Pharma adds hedge fund executive, 2 others to board

Embattled drug company Valeant Pharmaceuticals has added three directors to its board, including an executive from activist investor Bill Ackman's hedge fund Pershing Square Capital Management.

See Full Article

Its shares climbed nearly 4 per cent in premarket trading shortly ahead of the Wednesday market open.

The Canadian drugmaker said Wednesday that Pershing Vice Chairman Stephen Fraidin has joined the board, along with pharmaceutical executive Dr. Fred Eshelman and former University of North Carolina president Thomas W. Ross. Dr. Anders Lonner also is leaving, so these moves will bump the board's size to 14 members, 12 of whom are independent.

Pershing Square holds a 6.3 per cent stake in Valeant, as one of its biggest shareholders, according to FactSet.

Fraidin is an attorney specializing in mergers and acquisitions. Eshelman is the founder and former CEO of Pharmaceutical Product Development Inc. and has worked in the pharmaceutical industry for 35 years, Valeant said.

Valeant Pharmaceuticals International Inc. is facing a Securities and Exchange Commission investigation and, separately, scrutiny from Congress over its drug pricing. CEO Michael Pearson also recently returned to work after missing two months due to some health problems.

Valeant will discuss its preliminary fourth-quarter results and update its forecast for 2016 on March 15. The company had said last month it was delaying that announcement due to Pearson's return to work.

The company also has said it would delay filing its 2015 annual report with regulators while it sorts out its former relationship with the mail-order pharmacy Philidor, which has raised questions about the accuracy of Valeant's financial reporting.

U.S.-traded shares of Valeant jumped nearly 4 per cent, or $2.49, to $65.64 shortly before markets opening Wednesday. That's about a quarter of the all-time high of $263.81 that the stock reached in August, shortly before the company's practice of buying rights to old drugs and jacking up the prices came under congressional scrutiny.



Advertisements

Latest Economic News

  • Pot companies on hiring spree ahead of lucrative legal market

    Economic CBC News
    Considering a career in the cannabis business? Now may be the time to take the plunge as licensed marijuana companies ramp up production and rush to fill jobs ahead of pot's legalization in Canada on Oct. Source
  • #BuyCanadian campaign and Aeroplan rewards changes: CBC's Marketplace consumer cheat sheet

    Economic CBC News
    Miss something this week? Don't panic. CBC's Marketplace rounds up the consumer and health news you need. Want this in your inbox? Get the Marketplace newsletter every Friday. #BuyCanadian campaign Would you swear off buying American-made products? A number of Canadians on social media are resolving to #BuyCanadian in response to U.S. Source
  • OPEC and allies agree to share oil production increase

    Economic CTV News
    General view of a meeting of oil ministers of the Organization of the Petroleum Exporting Countries, OPEC, and non OPEC members at their headquarters in Vienna, Austria, Saturday, June 23, 2018. (AP Photo/Ronald Zak) Source
  • Tax tussle: Shaw loses bid to claim customers 'bought' paper invoices

    Economic CBC News
    An extensive court battle has seen Shaw Communications lose a bid to transfer tax responsibility for the cost of paper invoices onto the shoulders of customers. The B.C. Court of Appeal has dismissed the cable giant's argument that it shouldn't have to pay $1.66 million in provincial sales tax related to the material used to produce four years' worth of physical bills. Source
  • Johnson urges clean Brexit, 2 years after U.K. vote to quit EU

    Economic CTV News
    LONDON -- Leading Brexit supporters talked tough and their opponents took to the streets, as a divided U.K. marked the second anniversary on Saturday of its vote to leave the European Union. Britain voted on June 23, 2016 to quit the 28-nation EU, and its official exit is slated for March 29, 2019. Source
  • Pro-EU protesters march in London, demand new vote on Brexit

    Economic CTV News
    LONDON -- Thousands of anti-Brexit protesters marched Saturday in London to demand a new referendum on leaving the European Union, as a divided Britain marked the second anniversary of its vote to quit the bloc. Source
  • NEB approves modified Burnaby Terminal plans for Trans Mountain project

    Economic CTV News
    CALGARY -- The National Energy Board says it has approved modified plans for the Burnaby Terminal of the Trans Mountain pipeline project, clearing a final regulatory hurdle for construction to start. The regulator says the approved variance application will significantly improve safety at the terminal, which is the end point for the controversial pipeline the federal government has agreed to buy as part of a $4.5-billion acquisition of Kinder Morgan Canada's core assets. Source
  • Shopify to provide e-commerce platform for online B.C. cannabis sales

    Economic CTV News
    VANCOUVER -- British Columbia has selected Shopify Inc. to provide an e-commerce platform for the online sale of non-medical cannabis in the province. The Liquor Distribution Branch, which will be the sole wholesale distributor and public retailer of cannabis, says the Ottawa-based company was selected because of its proven record of on-time service, user-friendly design and approach to anticipating consumer needs. Source
  • Trump threatens 20% U.S. tariff on EU car imports

    Economic CBC News
    President Donald Trump on Friday threatened to escalate a trade war with Europe by imposing a 20 per cent tariff on all U.S. imports of European Union-assembled cars, a month after the administration launched an investigation into whether auto imports pose a national security threat. Source
  • BlackBerry shares slip on lower enterprise revenue

    Economic CBC News
    BlackBerry Ltd. shares sank almost 10 per cent to their lowest levels in weeks on Friday, despite beating analysts' estimates and reporting a solid start to its 2019 financial year. The company's stock was trading at $14.05, down $1.56, or 9.99 per cent, in late morning trading on the Toronto Stock Exchange. Source